Nachrichten zur Moderna Inc. Aktie

Walmart, Alibaba, Moderna, and More to Watch This Week

Home Depot, Lucid, TJX, and others also report earnings. Investors will see Fed minutes and economic data on manufacturing, home…

US Says Government, Not Moderna, Should Face COVID-19 Vaccine Lawsuit

US Says Government, Not Moderna, Should Face COVID-19 Vaccine Lawsuit …

Moderna fallen nach Studiendaten: Zinssorgen belasten US-Börsen

Die Inflationssorgen lassen die Anleger an der Wall Street zum Wochenschluss nicht los. Der Dow wird unter anderem vom Pharmakonzern…

Moderna Inc. stock underperforms Friday when compared to competitors

Moderna Inc. stock underperforms Friday when compared to competitors...…

Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more

Deere shares popped on strong earnings....…

Moderna Omicron booster cleared in Canada for children and adolescents

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna: Health Canada Authorizes Omicron-Targeting Vaccine in 6-to-17-Year-Olds

Moderna: Health Canada Authorizes Omicron-Targeting Vaccine in 6-to-17-Year-Olds...…

Dow Jones, S&P 500, Nasdaq: Inflationssorgen lasten auf US-Börsen – Moderna-Aktie gerät unter Druck

Die Experten von Goldman Sachs erwarten mittlerweile sogar drei weitere Zinsschritte in den USA. Die wichtigsten Indizes liegen zunächst im…

Moderna: Die Pipeline verbessert sich - Kaufen! Aktienanalyse

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Jefferies & Co: Die Analysten von Jefferies & Co stufen die Aktie von Moderna Inc.…

Moderna: Daten zum Grippeimpfstoff-Kandidaten fallen gemischt aus - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Moderna Inc. (ISIN: US60770K1079,…

Moderna Stock Falls as Study of Flu Vaccine Has Mixed Results

The shot got a strong immune response, but wasn't shown to be more effective than other vaccines....…

Coronavirus tally: Moderna flu vaccine trial falls short on one goal, sending stock down

Moderna Inc. stock was down 6.6% premarket Friday, after the COVID vaccine maker said a trial of a flu…

BioNTech-Konkurrent Moderna: Nur gemischte Daten bei Grippe-Impfstoff – Aktie unter Druck

Das US-Biotech-Unternehmen Moderna hat am Donnerstag nur gemischte Daten zu seinem Grippeimpfstoff-Kandidaten mRNA-1010 vorgelegt. Dies berichtet die Nachrichtenagentur Bloomberg....…

Moderna Buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Moderna nach Studiendaten zum Influenza-Impfstoff mRNA-1010 auf…

Moderna stock falls on mixed results of flu vaccine mRNA-1010 in phase 3 trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

DoorDash, DraftKings, Moderna, Redfin, and More Stock Market Movers

Fourth-quarter revenue at DoorDash rises 40%, and DraftKings boosts its guidance for fiscal 2023....…

Stocks to Watch: iBio, DoorDash, DraftKings, Moderna

Stocks to Watch: iBio, DoorDash, DraftKings, Moderna...…

After-Hours Alert: Why Moderna Stock Is Diving

Moderna Inc (NASDAQ: MRNA) shares are trading lower in Thursday's after-hours session after the company released interim Phase 3 safety and…

UPDATE 1-Moderna flu vaccine delivers mixed results in trial, shares fall

... Erman Feb 16 (Reuters) - Moderna Inc on Thursday said its closely......…

Moderna Shares Fall 5.9% on Mixed Results From Flu Shot Study

Moderna Shares Fall 5.9% on Mixed Results From Flu Shot Study...…

Moderna Flu Shot Gives Mixed Immune Results in Final-Stage Trial

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna stock falls 5% after flu vaccine study results

Moderna Inc. shares dove more than 5% in after-hours trading Thursday, after the company announced that a study into a…

Moderna flu vaccine delivers mixed results in trial

...By Patrick Wingrove and Michael Erman (Reuters) - Moderna Inc......…

Moderna, Inc.: Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate

mRNA-1010 demonstrated superiority on seroconversion rates for A/H3N2 and A/H1N1, superiority on geometric mean titer ratios for A/H3N2, and non-inferiority…

Pfizer/ BioNTech, Moderna set for 2024 trial in COVID vaccine patent dispute

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna’s COVID vaccine will remain free for all Americans in coup for Bernie Sanders

Moderna Inc. will keep its COVID-19 vaccine available and free of charge for all people in the U.S. even after…

Coronavirus tally: Moderna promises to keep COVID vaccine available and free for all Americans

Moderna Inc. will keep its COVID-19 vaccines available and free for all people in the U.S. after the public-health…

Moderna CEO to testify in senate on proposed vaccine price hike

...(Reuters) - Senator Bernie Sanders said on Wednesday Moderna......…

Moderna Inc. stock outperforms market on strong trading day

Moderna Inc. stock outperforms market on strong trading day...…

Moderna promises to keep COVID vaccine free

Moderna Inc. MRNA said Tuesday it will keep its COVID-19 vaccines available and free for all people in the U.S.…

Moderna CEO to face Senate hearing over pricing for COVID shot

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna CEO Stephane Bancel will testify before Senate next month on Covid vaccine price hike

Um den gesamten Artikel unter cnbc.com zu lesen, klicken Sie bitte auf die Überschrift...…

Federal government, not Moderna, should face COVID vaccine patent lawsuit, DoJ says

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit

...By Blake Brittain (Reuters) - The U.S. government should face......…

Moderna to offer free COVID shots even after pandemic emergency

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna Inc. stock outperforms competitors on strong trading day

Moderna Inc. stock outperforms competitors on strong trading day...…

Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

Moderna (MRNA) closed the most recent trading day at $171.48, moving +1.3% from the previous trading session....…

Insiderhandel: President verkauft Aktien von Moderna im Wert von 40.156$

Hoge, Stephen - Vorstand - Tag der Transaktion: 2023-02-10...…

Moderna Inc. stock rises Monday, still underperforms market

Moderna Inc. stock rises Monday, still underperforms market...…

Moderna, Cirrus Logic And Other Balance Sheet Powerhouses

These U.S. companies with market caps of at least $5 billion have earnings of at least 20 cents a share…

Insiderhandel: Aufsichtsrat verkauft Aktien von Moderna im Wert von 3.356.761$

Afeyan, Noubar - Aufsichtsrat - Tag der Transaktion: 2023-02-08...…

Fact Check-Moderna CEO did not say company made 100,000 COVID-19 vaccine doses before the pandemic started

...By Reuters Fact Check At Davos 2023, Moderna CEO Stephane Bancel.../pfbid02TsXTLtfZfs4kB4o4KWjwbYHtKJ4YQzNXZEUFgJxXxhqdwiMmBYY5FywYwP1eTRUnl). …

Moderna Inc. stock outperforms market on strong trading day

Moderna Inc. stock outperforms market on strong trading day...…

Corona-Impfstoffe von BioNTech und Moderna: Das ändert sich bald in den USA – die Folgen

Deutschland, die USA und viele Länder haben im Zuge der Corona-Pandemie Hunderte Millionen Impfdosen für ihre Länder bestellt. Nun will…

Bivalent COVID Vaccines Perform Worse Against Variant Now Dominant In United States: Studies

Bivalent COVID Vaccines Perform Worse Against Variant Now Dominant In United States: Studies …

Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could…

What Fauci Knew About Vaccine Ineffectiveness... And When

What Fauci Knew About Vaccine Ineffectiveness... And When Authored…

Moderna (MRNA) Gains But Lags Market: What You Should Know

Moderna (MRNA) closed the most recent trading day at $171.06, moving +0.46% from the previous trading session....…

Moderna Inc. stock rises Tuesday, still underperforms market

Moderna Inc. stock rises Tuesday, still underperforms market...…

Carisma Therapeutics Appoints Moderna CSO of External Research Ventures, Lin Guey, to Scientific Advisory Board

PHILADELPHIA, Feb. 7, 2023 /PRNewswire/ -- Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative…